883 related articles for article (PubMed ID: 16281260)
1. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
3. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
4. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
[TBL] [Abstract][Full Text] [Related]
5. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
6. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.
Tahara H; Shin-Ya K; Seimiya H; Yamada H; Tsuruo T; Ide T
Oncogene; 2006 Mar; 25(13):1955-66. PubMed ID: 16302000
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.
Hartmann U; Brümmendorf TH; Balabanov S; Thiede C; Illme T; Schaich M
Haematologica; 2005 Mar; 90(3):307-16. PubMed ID: 15749662
[TBL] [Abstract][Full Text] [Related]
8. Telomere instability and cancer.
Londoño-Vallejo JA
Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
[TBL] [Abstract][Full Text] [Related]
9. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
Arkus N
J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
[TBL] [Abstract][Full Text] [Related]
10. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.
Chan SW; Blackburn EH
Oncogene; 2002 Jan; 21(4):553-63. PubMed ID: 11850780
[TBL] [Abstract][Full Text] [Related]
11. Control of telomere length by the human telomeric protein TRF1.
van Steensel B; de Lange T
Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of telomeric instability.
Baird DM
Cytogenet Genome Res; 2008; 122(3-4):308-14. PubMed ID: 19188700
[TBL] [Abstract][Full Text] [Related]
13. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
14. Telomeres and chromosome instability.
Murnane JP
DNA Repair (Amst); 2006 Sep; 5(9-10):1082-92. PubMed ID: 16784900
[TBL] [Abstract][Full Text] [Related]
15. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
[TBL] [Abstract][Full Text] [Related]
16. A role for the Rb family of proteins in controlling telomere length.
García-Cao M; Gonzalo S; Dean D; Blasco MA
Nat Genet; 2002 Nov; 32(3):415-9. PubMed ID: 12379853
[TBL] [Abstract][Full Text] [Related]
17. Protection against chromosome degradation at the telomeres.
Grandin N; Charbonneau M
Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
[TBL] [Abstract][Full Text] [Related]
18. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Hills M; Lansdorp PM
Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
[TBL] [Abstract][Full Text] [Related]
19. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
[TBL] [Abstract][Full Text] [Related]
20. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
